January 29, 2018 / 7:43 AM / 3 months ago

Ablynx shares suspended after Sanofi bid - regulator

BRUSSELS (Reuters) - Shares of Belgian biotech group Ablynx (ABLX.BR) will be suspended until 1030 local time (0930 GMT), following a 45 euros epr share bid by French pharma group Sanofi (SASY.PA), the Belgian market regulator said.

FILE PHOTO: A logo is seen in front of the entrance at the headquarters French drugmaker Sanofi in Paris October 30, 2014. REUTERS/Christian Hartmann/File Photo

The shares were suspended to allow an “adequate dissemination of a press release”, the regulator said in a statement.

    Reporting by Robert-Jan Bartunek; editing by Philip Blenkinsop

    0 : 0
    • narrow-browser-and-phone
    • medium-browser-and-portrait-tablet
    • landscape-tablet
    • medium-wide-browser
    • wide-browser-and-larger
    • medium-browser-and-landscape-tablet
    • medium-wide-browser-and-larger
    • above-phone
    • portrait-tablet-and-above
    • above-portrait-tablet
    • landscape-tablet-and-above
    • landscape-tablet-and-medium-wide-browser
    • portrait-tablet-and-below
    • landscape-tablet-and-below